These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 15623653)
1. Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Xiao Y; Monitto CL; Minhas KM; Sidransky D Clin Cancer Res; 2004 Dec; 10(24):8683-6. PubMed ID: 15623653 [TBL] [Abstract][Full Text] [Related]
2. PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Liang J; Zubovitz J; Petrocelli T; Kotchetkov R; Connor MK; Han K; Lee JH; Ciarallo S; Catzavelos C; Beniston R; Franssen E; Slingerland JM Nat Med; 2002 Oct; 8(10):1153-60. PubMed ID: 12244302 [TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Viglietto G; Motti ML; Bruni P; Melillo RM; D'Alessio A; Califano D; Vinci F; Chiappetta G; Tsichlis P; Bellacosa A; Fusco A; Santoro M Nat Med; 2002 Oct; 8(10):1136-44. PubMed ID: 12244303 [TBL] [Abstract][Full Text] [Related]
4. Mutant epidermal growth factor receptor signaling down-regulates p27 through activation of the phosphatidylinositol 3-kinase/Akt pathway in glioblastomas. Narita Y; Nagane M; Mishima K; Huang HJ; Furnari FB; Cavenee WK Cancer Res; 2002 Nov; 62(22):6764-9. PubMed ID: 12438278 [TBL] [Abstract][Full Text] [Related]
5. Hypoxia-induced pRB hypophosphorylation results from downregulation of CDK and upregulation of PP1 activities. Krtolica A; Krucher NA; Ludlow JW Oncogene; 1998 Nov; 17(18):2295-304. PubMed ID: 9811460 [TBL] [Abstract][Full Text] [Related]
6. The role of p27Kip1 in gamma interferon-mediated growth arrest of mammary epithelial cells and related defects in mammary carcinoma cells. Harvat BL; Seth P; Jetten AM Oncogene; 1997 May; 14(17):2111-22. PubMed ID: 9160891 [TBL] [Abstract][Full Text] [Related]
7. G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein. Gonzales AJ; Fry DW Exp Cell Res; 2005 Feb; 303(1):56-67. PubMed ID: 15572027 [TBL] [Abstract][Full Text] [Related]
8. Genistein elicits pleiotropic molecular effects on head and neck cancer cells. Alhasan SA; Aranha O; Sarkar FH Clin Cancer Res; 2001 Dec; 7(12):4174-81. PubMed ID: 11751518 [TBL] [Abstract][Full Text] [Related]
9. Cell cycle kinase inhibitor expression and hypoxia-induced cell cycle arrest in human cancer cell lines. Box AH; Demetrick DJ Carcinogenesis; 2004 Dec; 25(12):2325-35. PubMed ID: 15347600 [TBL] [Abstract][Full Text] [Related]
10. p27KIP1 phosphorylation by PKB/Akt leads to poor breast cancer prognosis. Clarke RB Breast Cancer Res; 2003; 5(3):162-3. PubMed ID: 12793899 [No Abstract] [Full Text] [Related]
11. Iron-saturated lactoferrin stimulates cell cycle progression through PI3K/Akt pathway. Lee SH; Pyo CW; Hahm DH; Kim J; Choi SY Mol Cells; 2009 Jul; 28(1):37-42. PubMed ID: 19533041 [TBL] [Abstract][Full Text] [Related]
12. Oral lactoferrin results in T cell-dependent tumor inhibition of head and neck squamous cell carcinoma in vivo. Wolf JS; Li G; Varadhachary A; Petrak K; Schneyer M; Li D; Ongkasuwan J; Zhang X; Taylor RJ; Strome SE; O'Malley BW Clin Cancer Res; 2007 Mar; 13(5):1601-10. PubMed ID: 17332307 [TBL] [Abstract][Full Text] [Related]
13. Alleviation of doxorubicin adverse effects via loading into various drug-delivery systems: a comparative study. Abdel-Megeed RM; Ghanem HZ; Kadry MO Ther Deliv; 2024; 15(6):413-426. PubMed ID: 38639647 [TBL] [Abstract][Full Text] [Related]
14. Multifaceted Effects of Kinase Inhibitors on Pancreatic Cancer Cells Reveals Pivotal Entities with Therapeutic Implications. Kim YN; Patil K; Ma J; Dufek GA; Pai SB Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371811 [TBL] [Abstract][Full Text] [Related]
15. Time to Kill and Time to Heal: The Multifaceted Role of Lactoferrin and Lactoferricin in Host Defense. Ohradanova-Repic A; Praženicová R; Gebetsberger L; Moskalets T; Skrabana R; Cehlar O; Tajti G; Stockinger H; Leksa V Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111542 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells. Arredondo-Beltrán IG; Ramírez-Sánchez DA; Zazueta-García JR; Canizalez-Roman A; Angulo-Zamudio UA; Velazquez-Roman JA; Bolscher JGM; Nazmi K; León-Sicairos N Biometals; 2023 Jun; 36(3):639-655. PubMed ID: 36626098 [TBL] [Abstract][Full Text] [Related]
17. The effect of lactoferrin on ULK1 and ATG13 genes expression in breast cancer cell line MCF7 and bioinformatics studies of protein interaction between lactoferrin and the autophagy initiation complex. Karabi Z; Moradian F; Kheirabadi M Cell Biochem Biophys; 2022 Dec; 80(4):795-806. PubMed ID: 36169801 [TBL] [Abstract][Full Text] [Related]
18. Lactoferrin and its nano-formulations in rare eye diseases. Singh J; Sharma M; Jain N; Aftab I; Vikram N; Singh TP; Sharma P; Sharma S Indian J Ophthalmol; 2022 Jul; 70(7):2328-2334. PubMed ID: 35791114 [TBL] [Abstract][Full Text] [Related]
19. Lactoferrin as a Human Genome "Guardian"-An Overall Point of View. Bukowska-Ośko I; Sulejczak D; Kaczyńska K; Kleczkowska P; Kramkowski K; Popiel M; Wietrak E; Kowalczyk P Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563638 [TBL] [Abstract][Full Text] [Related]
20. Regulation of Ferroptosis by Non-Coding RNAs in Head and Neck Cancers. Hsieh PL; Chao SC; Chu PM; Yu CC Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328568 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]